These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
906 related articles for article (PubMed ID: 8248852)
21. Antibodies to a synthetic peptide can be used to distinguish between muscarinic acetylcholine receptor binding sites in brain and heart. Luthin GR; Harkness J; Artymyshyn RP; Wolfe BB Mol Pharmacol; 1988 Sep; 34(3):327-33. PubMed ID: 3419425 [TBL] [Abstract][Full Text] [Related]
22. Regional distribution of M1, M2 and non-M1, non-M2 subtypes of muscarinic binding sites in rat brain. Ehlert FJ; Tran LP J Pharmacol Exp Ther; 1990 Dec; 255(3):1148-57. PubMed ID: 2262898 [TBL] [Abstract][Full Text] [Related]
23. Differential changes in cholinergic markers from selected brain regions after specific immunolesion of the rat cholinergic basal forebrain system. Rossner S; Schliebs R; Perez-Polo JR; Wiley RG; Bigl V J Neurosci Res; 1995 Jan; 40(1):31-43. PubMed ID: 7714924 [TBL] [Abstract][Full Text] [Related]
24. Complex allosteric modulation of cardiac muscarinic receptors by protamine: potential model for putative endogenous ligands. Hu J; Wang SZ; Forray C; el-Fakahany EE Mol Pharmacol; 1992 Aug; 42(2):311-21. PubMed ID: 1513329 [TBL] [Abstract][Full Text] [Related]
25. Kinetic studies of [3H]-N-methylscopolamine binding to muscarinic receptors in the rat central nervous system: evidence for the existence of three classes of binding sites. Waelbroeck M; Gillard M; Robberecht P; Christophe J Mol Pharmacol; 1986 Oct; 30(4):305-14. PubMed ID: 3762520 [TBL] [Abstract][Full Text] [Related]
27. Thiochrome enhances acetylcholine affinity at muscarinic M4 receptors: receptor subtype selectivity via cooperativity rather than affinity. Lazareno S; Dolezal V; Popham A; Birdsall NJ Mol Pharmacol; 2004 Jan; 65(1):257-66. PubMed ID: 14722259 [TBL] [Abstract][Full Text] [Related]
28. Binding of selective antagonists to four muscarinic receptors (M1 to M4) in rat forebrain. Waelbroeck M; Tastenoy M; Camus J; Christophe J Mol Pharmacol; 1990 Aug; 38(2):267-73. PubMed ID: 2385234 [TBL] [Abstract][Full Text] [Related]
29. Allosteric interactions at the m1, m2 and m3 muscarinic receptor subtypes. Lee NH; el-Fakahany EE J Pharmacol Exp Ther; 1991 Feb; 256(2):468-79. PubMed ID: 1993991 [TBL] [Abstract][Full Text] [Related]
30. Regional distribution of muscarinic and nicotinic cholinergic receptor binding activities in the human brain. Perry EK; Smith CJ; Perry RH; Whitford C; Johnson M; Birdsall NJ J Chem Neuroanat; 1989; 2(4):189-99. PubMed ID: 2597358 [TBL] [Abstract][Full Text] [Related]
31. Different agonist-receptor active conformations for rat brain M1 and M2 muscarinic receptors that are separately coupled to two biochemical effector systems. McKinney M; Anderson D; Vella-Rountree L Mol Pharmacol; 1989 Jan; 35(1):39-47. PubMed ID: 2536467 [TBL] [Abstract][Full Text] [Related]
32. Multiple binding affinities of N-methylscopolamine to brain muscarinic acetylcholine receptors: differentiation from M1 and M2 receptor subtypes. el-Fakahany EE; Ramkumar V; Lai WS J Pharmacol Exp Ther; 1986 Aug; 238(2):554-63. PubMed ID: 3755473 [TBL] [Abstract][Full Text] [Related]
33. Distribution of central omega 1 (benzodiazepine1) and omega 2 (benzodiazepine2) receptor subtypes in the monkey and human brain. An autoradiographic study with [3H]flunitrazepam and the omega 1 selective ligand [3H]zolpidem. Dennis T; Dubois A; Benavides J; Scatton B J Pharmacol Exp Ther; 1988 Oct; 247(1):309-22. PubMed ID: 2845057 [TBL] [Abstract][Full Text] [Related]
34. Muscarinic receptor subtypes in human nasal mucosa: characterization, autoradiographic localization, and function in vitro. Okayama M; Mullol J; Baraniuk JN; Hausfeld JN; Feldman B; Merida M; Shelhamer JH; Kaliner MA Am J Respir Cell Mol Biol; 1993 Feb; 8(2):176-87. PubMed ID: 8427708 [TBL] [Abstract][Full Text] [Related]
35. Differential regulation of subtypes m1-m5 of muscarinic receptors in forebrain by chronic atropine administration. Wall SJ; Yasuda RP; Li M; Ciesla W; Wolfe BB J Pharmacol Exp Ther; 1992 Aug; 262(2):584-8. PubMed ID: 1323653 [TBL] [Abstract][Full Text] [Related]
36. Interactions of cocaine with primary and secondary recognition sites on muscarinic receptors. Flynn DD; Vaishnav AA; Mash DC Mol Pharmacol; 1992 Apr; 41(4):736-42. PubMed ID: 1569924 [TBL] [Abstract][Full Text] [Related]
37. Pharmacologic characterization of muscarinic receptors of insect brains. Abdallah EA; Eldefrawi ME; Eldefrawi AT Arch Insect Biochem Physiol; 1991; 17(2-3):107-18. PubMed ID: 1802028 [TBL] [Abstract][Full Text] [Related]
38. Prejunctional muscarinic receptors in the deep muscular plexus of canine ileum: comparison with smooth muscle receptors. Kostka P; Ahmad S; Kwan CY; Daniel EE; Gordon RK; Chiang PK J Pharmacol Exp Ther; 1992 Oct; 263(1):226-31. PubMed ID: 1403787 [TBL] [Abstract][Full Text] [Related]
39. Positive cooperativity in the binding of alcuronium and N-methylscopolamine to muscarinic acetylcholine receptors. Tucek S; Musílková J; Nedoma J; Proska J; Shelkovnikov S; Vorlícek J Mol Pharmacol; 1990 Nov; 38(5):674-80. PubMed ID: 2233700 [TBL] [Abstract][Full Text] [Related]
40. [3H]N-methylscopolamine binding studies reveal M2 and M3 muscarinic receptor subtypes on cerebellar granule cells in primary culture. Alonso R; Didier M; Soubrie P J Neurochem; 1990 Jul; 55(1):334-7. PubMed ID: 2355226 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]